TransRadial Ultra Support Technique (TRUST)

TransRadial Ultra Support Technique (TRUST Technique) Versus Anchoring Technique to Enhance Guiding Catheter Support: a Prospective Randomized Pilot Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03025685

Enrollment

Registered

2017-01-19

Start date

2016-09-30

Completion date

2016-12-31

Last updated

2017-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Arterioscleroses, Coronary Artery Disease

Keywords

Percutaneous Coronary Intervention, Coronary Artery Disease, Wire, Coronary stenting

Brief summary

Adequate support is required for challenging percutaneous coronary interventions (PCI). The TransRadial Ultra Support Technique (TRUST technique) is a new support technique that provides active support by deep pass of the coronary wire into the heart cavities (left ventricle-LV, right ventricle-RV) or aorta.

Interventions

PROCEDURETRUST technique

A soft hydrophilic wire easily pass through the invisible small vessels in the distal parts of a coronary artery into a heart cavity. It is necessary to pass a wire softly and forward as deep as possible. Quite often the wire goes through the left ventricle to aorta arch, and sometimes distal soft tip can be visible in a descending aorta. Thus the stiffest part of the wire become staying on all length of artery, straightening bends and giving the maximum support. After that balloons and stents can be delivered more easily

PROCEDUREAnchoring Technique

A standard endovascular technique of coronary wire support improvement

PROCEDURECoronary stenting

A standard endovascular procedure of percutaneous coronary intervention with coronary stenting

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Subjects singed informed consent form * Subjects eligible for percutaneous coronary intervention

Exclusion criteria

* Age \<18 years or \>75 years * Subject has a platelet count \< 100,000 cells/mm3 or \> 700,000 cells/mm3. * Known non-adherence to double anti-platelet therapy (DAPT) * LVEF \<30% * Continuing bleeding * Acute coronary syndrome (ST-elevation Myocardial infarction) * Pregnancy

Design outcomes

Primary

Measure	Time frame	Description
Procedural success	1 week after PCI	Device success without the occurrence of in-hospital MACCE
Device success	Intraoperative	Achievement of a final residual diameter stenosis \<20% and a TIMI 3 flow in the target vessel

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026